BioAtla’s Phase 3 Cancer Trial Is “AI-Backed”. Just Not in the Way You Think
BioAtla’s Oz-V SPV deal illustrates how AI is becoming a financing partner, not a discovery engine
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 13
BioAtla’s Oz-V SPV deal illustrates how AI is becoming a financing partner, not a discovery engine
"At the core of our approach is the belief that AI should augment human expertise, not replace it"
Eight deployments that moved beyond pilots and into routine care
A new partnership with Reimagine Care targets ER visits, hospitalizations, and clinician overload in oncology
The non-exclusive agreements point to immune-receptor datasets becoming infrastructure for AI-driven discovery
The company told investors it has saved more than $1 billion through internal efficiencies driven by AI and automation, money it plans to reinvest in growth and technology.
"Together, we can help life science companies reimagine how clinical trials are planned, launched, and managed, accelerating the journey from discovery to treatment"
"The largest initial investment in Alabama history"
"This is the first clinical validation of Recursion's AI platform"
Profluent is building on its claim that scaling laws, the principle that model performance improves predictably with more data and compute apply to protein design.
The academic health system is deploying Abridge across clinics and the ER, aiming to reduce workload and improve clarity for multilingual patients
The company’s FDA-cleared mammography AI marks a shift toward cloud-native imaging ecosystems that outlast hardware cycles
Following the launch of its “Alice” voice agent for post-enrollment service, EHealth pivots to full-lifecycle automation
AxisCare Intelligence was built to make home care operations easier, scalable, and more human by turning data into real-time insights that drive smarter decisions, stronger performance, and better outcomes.
Built with medical insight, Robyn offers structured emotional support through AI-driven reflection while maintaining clear ethical and safety boundaries.
Healthcare and insurance run on endless data, dense workflows, and strict rules. Autonomize AI helps teams cut through the noise.
AI has learned to speak. Now it’s learning to listen—to the brain itself.
"Companies can no longer afford to wait for insights, they need AI that acts"
Sepideh Naseri takes charge of CareSet’s data and AI strategy, focusing on healthcare analytics, machine learning, and responsible use of government health data.
Tala Health is pioneering the next generation of AI-native healthcare solutions that improve outcomes and reduce costs.